Rangachar Kasturi

Title: Rangachar Kasturi: Innovator in Neonatal Pain Assessment

Introduction

Rangachar Kasturi is a notable inventor based in Tampa, FL (US), recognized for his contributions to the field of neonatal pain assessment. With a total of 5 patents, he has made significant strides in developing innovative solutions that enhance the understanding and treatment of pain in neonatal patients.

Latest Patents

One of his latest patents is titled "Neonatal pain identification from neonatal facial expressions." This invention introduces a Neonatal CNN (N-CNN) designed to detect neonatal pain emotions based on facial recognition. The cascaded N-CNN is trained using a Neonatal Pain Assessment Database (NPAD) to automatically identify when a neonatal patient is experiencing pain in real-time. The results demonstrate that this automatic recognition of neonatal pain is a viable and more efficient alternative to the current standard of pain assessment. Another significant patent is the "Comprehensive and context-sensitive neonatal pain assessment system and methods using multiple modalities." This system and method automatically assess pediatric and neonatal pain by analyzing facial expressions, crying sounds, body movements, and changes in vital signs. This innovation aims to improve the diagnosis and treatment of pain in the pediatric patient population.

Career Highlights

Rangachar Kasturi has worked with esteemed organizations, including the University of South Florida and the Government of the United States of America, as represented by the Secretary of Commerce. His work has been pivotal in advancing the methodologies used in neonatal pain assessment.

Collaborations

Throughout his career, Kasturi has collaborated with notable colleagues such as Ghadh A Alzamzmi and Dmitry B Goldgof. Their combined expertise has contributed to the development of innovative solutions in the field.

Conclusion

Rangachar Kasturi's work in neonatal pain assessment showcases his dedication to improving healthcare for vulnerable populations. His innovative patents reflect a commitment to enhancing the accuracy and efficiency of pain assessment in neonates.